State Key Laboratory of Oncology in South China
In research, State Key Laboratory of Oncology in South China stands highest in Medicine (#856 of 10,443 worldwide), Health Sciences (#1,293 of 11,982 worldwide) and Life Sciences (#2,250 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 16.8× its share of world research.
- World rank, 2022–2025
- #3,494 of 28,054 · #5,988 all time
- Rank in ??
- #39 of 692
- Research works
- 1.4k ▲ 58% vs 2013–17
- Citations
- 38k 27.8 per fractional work
- Top-10% rate
- 27.5% record average 16.5%
- Open access
- 59% world 28%
What is State Key Laboratory of Oncology in South China known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #856 of 10,443 | 25.6% | 218 | #1369 | |
| Health SciencesDomain | #1,293 of 11,982 | 25.5% | 222 | #1845 | |
| Life SciencesDomain | #2,250 of 7,800 | 34.5% | 72 | #3662 |
Each strip is that field’s whole ranked pool, with the notch where State Key Laboratory of Oncology in South China sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#1,369 #856
- Health Sciences#1,845 #1,293
- Life Sciences#3,662 #2,250
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does State Key Laboratory of Oncology in South China specialise in?
Where its research is concentrated relative to its size: Oncology takes 16.8× the share of its output that it takes of world research.
- OncologySubfield · 58.5 works17×
- Pulmonary and Respiratory MedicineSubfield · 39.6 works8.3×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.7×. Every wedge is a field page.
- Medicine 3.7×
- Biochemistry, Genetics and Molecular Biology 3.5×
- Immunology and Microbiology 3.3×
- Nursing 0.7×
- Neuroscience 0.6×
- Dentistry 0.5×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Physics and Astronomy 0.4×
- Veterinary 0.2×
- Health Professions 0.2×
- Chemistry 0.2×
- Mathematics 0.2×
- Materials Science 0.1×
- Computer Science 0.1×
- Economics, Econometrics and Finance 0.1×
- Engineering 0.1×
- Environmental Science 0.1×
- Psychology 0.1×
- Agricultural and Biological Sciences 0.0×
- Decision Sciences 0.0×
- Social Sciences 0.0×
- Earth and Planetary Sciences 0.0×
- Energy 0.0×
- Business, Management and Accounting 0.0×
Which keywords describe research at State Key Laboratory of Oncology in South China?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Tumor Microenvironment, Cancer, Immunotherapy, Radiotherapy, Clinical Practice Guidelines, Prognostic Factors and Survival.
- Lipid Peroxidation
- Radiofrequency Ablation
- Immunity
- Tumor Markers
- Survival Analysis
- Cell Death
- Oropharyngeal Cancer
- Endoscopic Resection
- Molecular Characterization
- Precision Medicine
- Prognosis
- Treatment
- Gene Expression
- PD-1 and PD-L1
- Clinical Trials
- Neoadjuvant Therapy
- Survival
- Clinical Practice Guidelines
- Immunotherapy
- Tumor Microenvironment
- Chemotherapy
- Cancer
- Radiotherapy
- Prognostic Factors
- Targeted Therapy
- Inflammation
- Immune Checkpoint Blockade
- Metastasis
- Cetuximab
- Human Papillomavirus
- Biomarkers
- Management
- Squamous Cell Carcinoma
- Nasopharyngeal Carcinoma
- Hepatocellular Carcinoma
- Chemoradiation
- Preoperative Chemoradiotherapy
- Surgical Management
- Liver Cancer
- Adjuvant Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy49▲ 23×21 topics
- Tumor Microenvironment38▲ 28×8 topics
- Cancer35▲ 8.5×39 topics
- Immunotherapy28▲ 13×17 topics
- Radiotherapy26▲ 22×13 topics
- Clinical Practice Guidelines23▲ 14×12 topics
- Prognostic Factors23▲ 17×13 topics
- Survival22▲ 53×4 topics
- Targeted Therapy19▲ 28×4 topics
- Neoadjuvant Therapy19▲ 26×5 topics
- Inflammation18▲ 2.7×55 topics
- Clinical Trials17▲ 8.3×11 topics
- Immune Checkpoint Blockade17▲ 50×1 topic
- PD-1 and PD-L117▲ 50×1 topic
- Metastasis17▲ 16×12 topics
- Gene Expression16▲ 8.6×11 topics
- Cetuximab15▲ 60×2 topics
- Treatment14▲ 3.8×22 topics
- Human Papillomavirus14▲ 37×3 topics
- Prognosis14▲ 14×7 topics
- Biomarkers13▲ 6.0×12 topics
- Precision Medicine13▲ 8.8×7 topics
- Management12▲ 5.1×13 topics
- Molecular Characterization12▲ 22×5 topics
- Squamous Cell Carcinoma12▲ 45×3 topics
- Endoscopic Resection12▲ 39×2 topics
- Nasopharyngeal Carcinoma12▲ 75×1 topic
- Oropharyngeal Cancer12▲ 75×1 topic
- Hepatocellular Carcinoma12▲ 18×3 topics
- Cell Death12▲ 16×6 topics
- Chemoradiation11▲ 53×2 topics
- Survival Analysis11▲ 13×7 topics
- Preoperative Chemoradiotherapy10▲ 41×2 topics
- Tumor Markers10▲ 39×2 topics
- Surgical Management10▲ 7.6×8 topics
- Immunity10▲ 7.7×7 topics
- Liver Cancer10▲ 56×1 topic
- Radiofrequency Ablation10▲ 30×1 topic
- Adjuvant Therapy9▲ 23×2 topics
- Lipid Peroxidation9▲ 28×3 topics
Which research topics does State Key Laboratory of Oncology in South China publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Head and Neck Cancer Studies, Hepatocellular Carcinoma Treatment and Prognosis and Ferroptosis and cancer prognosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 17 works
- 2 Head and Neck Cancer Studies Otorhinolaryngology 12 works
- 3 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 10 works
- 4 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 9 works
- 5 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 8 works
- 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 8 works
- 7 Esophageal Cancer Research and Treatment Surgery 7 works
- 8 Lung Cancer Research Studies Oncology 7 works
- 9 RNA modifications and cancer Molecular Biology 6 works
- 10 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 6 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has State Key Laboratory of Oncology in South China's research output changed?
Output in 2018–2022 was 58% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Guangzhou
- State Key Laboratory of Optoelectronic Materials and Technology
- State Key Laboratory of Luminescent Materials and Devices
- Guangdong Technical College of Water Resources and Electric Engineering
- Guangzhou College of Commerce
- Guangdong Peizheng College
- Guangzhou City Polytechnic
- Zhongshan Ophthalmic Center, Sun Yat-sen University
- Guangzhou Xinhua University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.